Eysins, Switzerland

Biosafe S.a.

Calculating rank
USPTO Granted Patents = 15


Trademarks = 5

Forward Citations = 167

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Julien Pierre Camisani (8 out of 8 patents)

silverMedal Pau Mato Sabat (4 out of 4 patents)

bronzeMedal Claude Fell (3 out of 5 patents)

4.  Olivier Waridel (2 out of 2 patents)

5.  Yannick Andre Sublet (2 out of 2 patents)

6.  Stuart Milne (1 out of 8 patents)

7.  Christopher Creasey (1 out of 8 patents)

8.  Stephen Lamb (1 out of 7 patents)

9.  Oliver Link (1 out of 1 patent)

10.  George John Morris (1 out of 12 patents)

11.  Klas Marteleur (1 out of 5 patents)

12.  Bertrand Marcel Alexandre Foucaut (1 out of 1 patent)

13.  Daniel De Melo (1 out of 1 patent)

14.  Daniel Augusto De Melo (1 out of 1 patent)

15.  Rupert Rutledge (1 out of 1 patent)


15 patents:

Company Overview
Biosafe S.a. is a Swiss company specializing in innovative solutions for the biopharmaceutical industry. The organization focuses on the development and manufacturing of advanced technologies for cell and gene therapy, particularly in the areas of bioprocessing and biopreservation. With a commitment to enhancing the efficiency and safety of biomanufacturing processes, Biosafe plays a crucial role in supporting the global healthcare landscape through its cutting-edge products and services.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

Biosafe S.a. USPTO Patent Assignee Logo
15 Patents

#1 in Eysins

#807 in Switzerland

#40,104 in the World

Eysins, CH
Eysins, Switzerland
Forward Citations = 167

19 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biosafe S.a.. Retrieved from https://idiyas.com/company/biosafe-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…